Distribution shifting
AI enabled
Xylo is designing drugs that induce the therapeutic benefits and neuroplasticity of psychedelics without the hallucinogenic and cardiotoxic side effects. While traditional, hallucinogenic psychedelics will always have a place, we believe that “non-hallucinogenic psychedelics” will appeal to a much broader market.
Under the radar for now - more info soon.
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance
